159711_CD
Reed_NN
Report_NN
103-142_CD
7_CD
3_CD
06_CD
12:05_CD
Page_NN
137_CD
Reed_NN
Elsevier_NN
Annual_JJ
Reports_NN
and_PHC
Financial_NN
Statements_NOMZ
2005_CD
137_CD
20_CD
Principal_NN
joint_JJ
ventures_NN
%_NN
holding_VBG [PRIV] [WZPRES]
Reed_NN
Elsevier_NN
Group_NN
plc_NN
Incorporated_NN
and_CC
operating_VBG
in_PIN
Great_NN
Britain_NN
10,000_CD
ordinary_JJ
R_NN
shares_NN
1-3_JJ
Strand_NN
10,000_CD
ordinary_JJ
E_NN
shares_NN
100_CD
%_NN
London_NN
WC2N_NN
5JR_NN
100,000_CD
7.5_CD
%_NN
cumulative_JJ
preference_NN
non_NN
voting_VBG [SUAV] [THATD] [WZPRES]
shares_NN
Holding_VBG [PRIV] [WZPRES]
company_NN
for_PIN
operating_VBG
businesses_NOMZ
involved_VBN [WZPAST]
in_PIN
science_NN
&_CC
medical_JJ
,_,
legal_JJ
,_,
educational_JJ
and_CC
business_NOMZ
publishing_GER
Equivalent_NN
to_PIN
a_DT
50_CD
%_NN
equity_NOMZ
interest_NN
Elsevier_NN
Reed_NN
Finance_NN
BV_NN
Incorporated_NN
in_PIN
the_DT
Netherlands_NN
133_CD
ordinary_JJ
R_NN
shares_NN
Radarweg_NN
29_CD
205_CD
ordinary_JJ
E_NN
shares_NN
100_CD
%_NN
1043_CD
NX_NN
Amsterdam_NN
,_,
The_DT
Netherlands_NN
Holding_GER
company_NN
for_PIN
financing_GER
businesses_NOMZ
Equivalent_NN
to_PIN
a_DT
61_CD
%_NN
equity_NOMZ
interest_NN
The_DT
R_NN
shares_NN
in_PIN
Reed_NN
Elsevier_NN
Group_NN
plc_NN
and_PHC
Elsevier_NN
Reed_NN
Finance_NN
BV_NN
are_VPRT [BYPA]
owned_VBN
by_PIN
Reed_NN
Elsevier_NN
PLC._NN
._.
In_CONJ
addition_NULL
,_,
Reed_NN
Elsevier_NN
NV_NN
holds_VPRT [PRIV]
a0_CD
.14_CD
m_NN
par_NN
value_NN
in_PIN
shares_NN
with_PIN
special_JJ
dividend_NN
rights_NN
in_PIN
Reed_NN
Elsevier_NN
Overseas_NN
BV_NN
and_PHC
Reed_NN
Elsevier_NN
Nederland_NN
BV_NN
,_,
both_DT
with_PIN
registered_VBN
offices_NN
in_PIN
Amsterdam_NN
._.
These_DEMO
shares_NN
are_VPRT [PASS]
included_VBN
in_PIN
the_DT
amount_NN
shown_VBN [PRIV]
under_IN
investments_NOMZ
in_PIN
joint_JJ
ventures_NN
._.
They_TPP3
enable_VPRT
Reed_NN
Elsevier_NN
NV_NN
to_TO
receive_VB
dividends_NN
from_PIN
companies_NN
within_PIN
the_DT
same_JJ
tax_NN
jurisdiction_NOMZ
._.
A_DT
list_NN
of_PIN
companies_NN
within_PIN
Reed_NN
Elsevier_NN
is_VPRT [PASS]
filed_VBN
with_PIN
the_DT
Amsterdam_NN
Chamber_NN
of_PIN
Commerce_NN
in_PIN
the_DT
Netherlands_NN
._.
21_CD
Approval_NN
of_PIN
financial_JJ
statements_NOMZ
The_DT
consolidated_JJ
financial_JJ
statements_NOMZ
were_VBD [PASS]
signed_VBN
and_PHC
authorised_VBN
for_PIN
issue_NN
by_PIN
the_DT
Combined_NN
Board_NN
of_PIN
directors_NN
on_PIN
15_CD
February_NN
2006_CD
._.
J_NN
Hommen_NN
M_NN
H_NN
Armour_NN
Chairman_NN
Chief_NN
Financial_NN
Officer_NN
